National Burden of Macrolide-Resistant Streptococcus Pneumoniae in the United States From Blood and Respiratory Tract Cultures Approaches 40 Percent


You May Also Like

CytomX Therapeutics to Announce Third Quarter 2018 Financial Results

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

Punjab province in Pakistan signs agreement with Novartis Access against chronic diseases

Poor patients in Punjab will have access to high-quality  medicines against noncommunicable, chronic diseases ...